论文部分内容阅读
为了了解肝炎后肝硬化患者行脾切除术后肝癌发生率,我们对632名肝炎后肝硬化患者进行了回顾性调查,现报告如下.632例患者均为诊断明确的乙型肝炎后肝硬化(失代偿期),其中新疆阿勒泰市106例,青海省西宁市282例,山西省运城市127例,甘肃省敦煌市117例.男性394例,女238例.年龄20～52岁,平均40.3岁.病程2～28年,平均12.4年.所有病人均因巨脾、脾功能亢进、反复食管静脉曲张破裂出血而行脾切除术,调查术后5年肝癌发生率.结果291例在脾切除术后5年内发展为肝癌,肝癌发生率为46%.
To understand the incidence of post-splenectomy liver cancer in patients with posthepatitic cirrhosis, we retrospectively reviewed 632 patients with posthepatitic cirrhosis and are reported below. All of the 632 patients were diagnosed with post-hepatitis B cirrhosis Among them, 106 cases were from Altay, Xinjiang, 282 cases from Xining, Qinghai Province, 127 cases from Yuncheng, Shanxi Province and 117 cases from Dunhuang, Gansu Province. There were 394 males and 238 females, aged from 20 to 52 years with an average of 40.3 Aged 2 to 28 years, an average of 12.4 years All patients were splenomegaly due to splenomegaly, repeated esophageal variceal bleeding and splenectomy to investigate the incidence of liver cancer after 5 years.Results 291 cases of splenectomy Five years after the development of liver cancer, liver cancer was 46%.